Comparison 7.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Observed number of pregnancies (all women) | 7 | 1035 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.26 [0.11, 0.63] |
2 Any side effect | 4 | 746 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.62 [0.43, 0.91] |
3 Specific side effects | 2 | Risk Ratio (M‐H, Fixed, 95% CI) | Subtotals only | |
3.1 Spotting/bleeding after treatment | 2 | 331 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.82 [0.69, 4.77] |
4 Menses | 4 | 667 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.14 [0.78, 1.68] |
4.1 Delay | 4 | 667 | Risk Ratio (M‐H, Fixed, 95% CI) | 1.14 [0.78, 1.68] |